OP
STJ

Omni Partners’s St Jude Medical STJ Stock Holding History

Omni Partners’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-886,083
Closed -$71.1M – 32
2016
Q4 		$71.1M Buy
886,083
+398,392
+82% +$31.6M 15.9% 1
2016
Q3 		$38.9M Buy
487,691
+88,610
+22% +$7.15M 11.32% 4
2016
Q2 		$31.1M Buy
+399,081
New +$28.5M 11.79% 3

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Omni Partners's STJ Position: Q1 2017 in Review

Omni Partners sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 886,083 shares — an estimated $71.1M sold.

Omni Partners first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $71.1M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Omni Partners reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Omni Partners sold 886,083 St Jude Medical shares in Q1 2017, an estimated $71.1M.
  • Omni Partners first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Omni Partners's St Jude Medical position peaked at $71.1M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Omni Partners's 13F filing for Q1 2017, filed 12 May 2017.